CCDC170 is a coiled-coil domain-containing protein that affects apoptosis of breast cancer cells through the IRE1 pathway, and a few studies have reported that ESR1-CCDC170 fusion is a carcinogenic fusion driver for breast cancer [55, 56]. Here, CCDC192 is linked to breast carcinoma.